Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON43858Phase 4Active, not recruiting
Phase 4, randomised, double-blind trial in hypothyroidism comparing Levothyroxine with Placebo (2 arms). Primary endpoint: Change in disease-specific quality of life and symptom burden. Started Apr 2013; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON43858.